Leadership
Richard T. Silver, M.D.
Dr. Richard Silver is Professor of Medicine at Weill Cornell Medical College. He received his M.D. from Cornell, where he also completed his postgraduate training in internal medicine and hematology. From the time of his early work as Clinical Associate, Leukemia Service, General Medicine Branch, National Cancer Institute, Dr. Silver has contributed to the development of modern clinical cancer chemotherapy.
Driven to increase collaboration and improve therapy for blood cancer patients, Dr. Silver returned to Weill Cornell and helped establish a Residency Training Program as a Visiting Fulbright Professor at the University of Bahia, Salvador, Brazil. This collaboration with the University of Bahia was also supported, in part, by the Rockefeller Foundation and still exists today. While in Brazil, he was able to journey to study the blood groups of the native people of the upper Xingu River region, where he discovered a new blood subgroup.
He is internationally recognized as one of the pioneers in clinical investigation of the MPNs, including CML. Among his many accomplishments in the field, Dr. Silver has steered the development and broad clinical application of interferons for the treatment of these diseases, and continues to be an actively practicing and publishing leader in clinical research in the MPNs. He is widely credited with developing the use of the bone marrow biopsy technique that is used throughout the world for the diagnosis of hematologic disorders. He has written over 300 peer-reviewed articles, written or edited more than four books and 20 chapters and innumerable abstracts. He is routinely listed among the Best Doctors in New York.
He has organized or has been invited to speak at numerous national and international meetings, and consensus conferences, and has had many distinguished visiting professorships. Among his many honors for his work in myeloproliferative neoplasms, he has been awarded the Catherine Pasmantier Award, the Timothy Gee Award of the Sass & Straus Leukemia Foundation, the Lifetime Achievement Award of the Cancer Research and Treatment Fund, and the Lifetime Achievement Award of the SASS Foundation for Medical Research. He has also received an Award from the Dean of Weill Cornell Medical College for “Lifetime of Academic Achievement, Dedication and Service”, the Honorary Lifetime Achievement Awards from the Israeli Society of Hematology and the University of Texas MD Anderson Cancer Center, the Weill Cornell Alumni Association and the Myeloproliferative Neoplasms (MPN) Heroes Award. He has been past President of Weill Cornell Alumni Association; Editor of the Cornell Alumni Magazine for a decade, and has served for years as a Senior Advisor to the Weill Cornell Alumni Association. He is a Life Member of the Cornell University Council. The Silver MPN Center has been named in his honor to recognize his enduring commitment and contributions to the understanding and treatment of myeloproliferative neoplasms.
Hematology/Oncology
Gail J. Roboz, M.D.
Gail J. Roboz, M.D.
Dr. Roboz is Professor of Medicine at Weill Cornell Medical College. She is co-director of the Myeloid Malignancies section of the Hematologic Malignancies program of the Cancer Center. A summa cum laude graduate of Yale University, she received her M.D. from The Mount Sinai School of Medicine, where she achieved the highest standing in the graduating class and was elected to the Alpha Omega Alpha honorary society. She did her internship and residency at the Beth Israel Hospital in Boston and New York-Presbyterian Hospital/Weill Cornell, where she also completed her fellowship in hematology-oncology.
Her research interests are in developmental therapeutics for acute leukemia, the myeloproliferative neoplasms, and myelodysplastic syndrome. Dr. Roboz has been the principal investigator of numerous major clinical trials, has authored many key publications the area, and served in leadership positions of national organizations in hematology and hematologic malignancies.
Clinical Profile (POPS)
Pinkal Desai, M.D.
Pinkal Desai, M.D.
Dr. Desai is an Assistant Professor of Medicine at Weill Cornell Medical College and Assistant Attending Physician at NewYork-Presbyterian Hospital. She received her M.D. and also her Master’s degree in Public Health from the University of Alabama at Birmingham, and completed her internal medicine residency at Wayne State University, Detroit Medical Center, and her fellowship in hematology-oncology at the Providence Hospital Medical Center where she also served as Chief Fellow from 2012-2013. She devotes her clinical practice to patients with leukemia, myelodysplastic syndrome (MDS) and myeloproliferative neoplasms and leads several clinical and translational research protocols in these areas.
Clinical Profile (POPS)
Michael S. Samuel, M.D.
Maria DeSancho, M.D.
Maria DeSancho, M.D.
Dr. Maria DeSancho is an Associate Professor of Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine. She received her medical degree from the Autonomous University in Spain and completed residencies at the La Paz Hospital in Spain and the Metropolitan Hospital Center in New York, with fellowships in hematology at Montefiore Medical Center and the Mount Sinai Medical Center, including advanced training in transfusion medicine and bone marrow transplantation. Prior to joining the Weill Cornell faculty in 2006, she was Assistant Clinical Professor at Columbia University and Assistant Attending Physician at the Mount Sinai Medical Center in New York.
Dr. DeSancho serves as Chief of the Non-Malignant Hematology Service. Dr. DeSancho has a special interest in bleeding and thrombotic disorders including in the myeloproliferative neoplasms (MPNs), particularly in pregnant and postpartum women. Dr. DeSancho diagnoses, treats and follows patients with myeloproliferative neoplasms. Additionally, Dr. DeSancho participates in a bi-monthly myeloproliferative neoplasms conference run by the Hematology and Medical Oncology Division in conjunction with the Pathology Department, as part of NewYork-Presbyterian and Weill Cornell Medicine’s commitment to offer MPN patients the best possible treatment using a multidisciplinary approach.
Clinical Profile (POPS)(646) 962-2065
Raymond D. Pastore, M.D.
Raymond D. Pastore, M.D.
Dr. Pastore received his undergraduate degree summa cum laude from Princeton University, his medical degree with Honors from the NYU School of Medicine, and performed his residency in internal medicine as well as his fellowship in hematology and medical oncology at Weill Cornell Medical Center. He was Chief Medical Resident from 2001-2002. During his training, he received a Master of Science degree in Clinical Epidemiology & Health Services Research from the Weill Cornell Graduate School of Medical Sciences.
Dr. Pastore sees patients and develops a clinical and translational research program related to non-malignant blood disorders. He is also involved in teaching hematology-oncology fellows, medical residents and medical students.
Clinical Profile (POPS)
Sebastian Mayer, M.D.
Sebastian Mayer, M.D.
Sebastian Mayer has been an attending physician on the Blood and Marrow Transplantation service at Weill Cornell Medical Center since 2010, after working on the Leukemia Service for two years. A native of Austria, he earned his MD at the University of Vienna with a Doctoral thesis in experimental nuclear medicine. After two years of nuclear medicine research in Vienna, Dr. Mayer completed his Internal Medicine residency at St. Luke’s Roosevelt Hospital center in New York. During that time, he participated in research projects on the molecular biology of lymphoma at Mount Sinai Medical Center and Albert Einstein College of Medicine.
After a fellowship in Hematology/Oncology and a subsequent faculty appointment at Mount Sinai Medical Center, he completed a fellowship in Stem Cell Transplantation at Memorial Sloan Kettering Cancer Center. His main research interests lie in the reversal of chemotherapy resistance in leukemia before stem cell transplant, specifically for patients with a high risk of disease recurrence. He also is an active investigator in the treatment of graft versus host disease, a feared complication of stem cell transplant, as well as the prevention and management of transplant rejection.
Clinical Profile (POPS)
Alexandra Gomez Arteaga, M.D.
Alexandra Gomez Arteaga, M.D.
Alexandra Gomez Arteaga, M.D., is Assistant Professor of Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine/New York-Presbyterian Hospital. She specializes in the care of patients with hematological malignancies and other disorders who need a blood or bone marrow stem cell transplant or cellular therapies.Dr. Gomez received her M.D. (Valedictorian) from Los Andes University in Bogota, Colombia, in 2011. She completed her Internal Medicine residency at the University of Miami/Jackson Memorial Hospital and her Hematology/Oncology fellowship at Weill Cornell Medicine/New York-Presbyterian Hospital, where she also served as Chief Fellow. Subsequently, she completed an advanced fellowship in Bone Marrow Transplantation at Memorial Sloan Kettering Cancer Center. Upon completion of her training, Dr. Gomez was recruited back to Weill Cornell Medicine/New York-Presbyterian Hospital to join the faculty of the Bone Marrow Transplant Program.Dr. Gomez’s main research focus is relapse prevention strategies and management of disease relapse after a stem cell transplant. She has published in leading internationally circulated peer-reviewed journals, among them Cancer, Biology of Blood and Marrow Transplantation, Bone Marrow Transplantation, the American Journal of Hematology, Leukemia & Lymphoma. She is a member of the American Society for Transplantation and Cellular Therapy (ASTCT), the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), and the Society for Immunotherapy of Cancer (SITC).
Clinical Profile (POPS)
Daniel Choi, M.D.
Daniel Choi, M.D.
Daniel Choi, MD, is an Instructor in Medicine at Weill Cornell Medical College and an Assistant Attending Physician at the New York-Presbyterian Hospital. Dr. Choi earned his medical degree from the Icahn School of Medicine at Mount Sinai in New York in 2016. He completed his residency training in Internal Medicine at Montefiore Medical Center in the Bronx in 2019 and his fellowship training in Hematology and Medical Oncology at NewYork-Presbyterian Hospital/Weill Cornell Medicine in 2022.
Dr. Choi is a physician-scientist conducting laboratory research focused on the stem cell biology of myeloproliferative neoplasms (MPNs). In addition to his laboratory research, he specializes in the clinical care of patients with myeloid malignancies including MPNs and leukemias at Weill Cornell Medicine.
Clinical Profile (POPS)
Franco Castillo Tokumori, M.D.
Franco Castillo Tokumori, M.D.
Franco Castillo Tokumori, M.D., is an Instructor in Medicine within the Division of Hematology and Medical Oncology at Weill Cornell Medicine and Assistant Attending physician at NewYork-Presbyterian Hospital. Dr. Castillo Tokumori treats patients with various blood conditions, with a special interest in caring for those with myeloproliferative neoplasms (MPNs), which has been the primary focus of his research.
Dr. Castillo Tokumori received his M.D. from Universidad Peruana Cayetano Heredia in 2016. After graduating, he worked in his home university’s Pediatric Infectious Diseases Laboratory and completed a postgraduate Diploma in Immunology. He then completed his residency training in Internal Medicine (2022) at the University of South Florida, where he also served as chief resident. He completed his fellowship in Hematology and Medical Oncology (2025) at Weill Cornell Medicine and NewYork-Presbyterian (WCM/NYP). He is a physician-scientist working closely with the Richard T. Silver MD Myeloproliferative Neoplasm (MPN) Center and the Dr. Joseph Scandura Laboratory at Weill Cornell Medicine. Dr. Castillo Tokumori’s laboratory and clinical research is focused on developing new methods to measure disease activity in MPNs. His work in single-cell techniques to assess clonal dynamics in MPNs has been recognized by the American Society of Hematology (ASH) in the form of a career development grant.
Clinical Profile (POPS)Pediatric Hematology & Oncology
Nicole Kucine, M.D.
Nicole Kucine, M.D.
Dr. Nicole Kucine is an Assistant Professor of Pediatrics at Weill Cornell Medical College, and has special expertise and interest in working with children with blood disorders including myeloproliferative disorders and secondary and hereditary polycythemias and thrombocytosis. She is a graduate of Wellesly College and received her M.D. from the State University of New York Health Science Center in Brooklyn (now SUNY-Downstate Medical Center).
She completed her residency in pediatrics at Robert Wood Johnson University Hospital of Rutgers University, where she also served as Chief Resident. She joined the Pediatrics faculty at Cornell after completing her fellowship in Pediatric Hematology and Oncology at the combined programs of NewYork-Presbyterian Hospital/Weill Cornell and the memorial Sloan-Kettering Cancer Center, where she was a Special Fellow working in the treatment of childhood hematologic malignancies. She is currently the principal investigator of a project to “study pediatric patients with myeloproliferative neoplasms.”
Clinical Profile (POPS)Hematopathology
Madhu Ouseph, M.D., Ph.D.
Madhu Ouseph, M.D., Ph.D.
Dr. Ouseph completed his Anatomic and Clinical Pathology Residency training at Brown University, Hematopathology Fellowship at Brigham and Women’s Hospital/Harvard University and Molecular Genetic Pathology Fellowship at Stanford University. His primary research interests include mutational spectrum of myeloid neoplasia and clonal hematopoiesis, and regulation or cell cycle, ploidy and DNA damage response.
Giorgio Inghirami, M.D.
Giorgio Inghirami, M.D.
Dr. Inghirami is a practicing hematopathologist, who joined Weill Cornell Medical College in September 2013, as a Professor of Pathology and Laboratory Medicine. He has worked in the field of molecular biology for the last 2O years, defining the role and distribution of pathogenetic defects among lymphoproliferative disorders. Detection of any given abnormality is believed to improve diagnostic accuracy, and helps to provide clinical-proven stratification. Indeed, patient - specific genomic fingerprints will appropriately predict clinical outcomes, pin - point patient selective targets and thus tailor therapies. Restricted defects in individual leukemia/lymphoma patients provide the means to efficiently assess Minimal Residual Disease (MRD) burden and to appropriately adjust therapeutic programs.
Dr. Inghirami has contributed more than 160 peer-reviewed publications, mostly in the area of lymphoma research, to the medical and scientific literature. He has underwritten several international patents and has been the Principal Investigator of several NIH-NCI, EU and Italian grants. He has also been part of a multicentric program sponsored by the Italian Cancer Research Association (AIRC) on "genetics-driven targeted management", and, he is a cofounder of The European T-Cell Lymphoma Study Group.
Julia Geyer, M.D.
Julia Geyer, M.D.
Dr. Julia Turbiner Geyer completed medical school at the Faculty of Medicine of the National Autonomous University of Mexico, Latin America's largest university in 2002. She subsequently completed residency training in Anatomic and Clinical Pathology at the Massachusetts General Hospital, Harvard Medical School (2003-2007); followed by a one-year fellowship in General Surgical Pathology (2008, MGH) and a fellowship in Hematopathology (2009, MGH) under the mentorship of Dr. Nancy Lee Harris.
Dermatology
Horatio Wildman, M.D.
Horatio Wildman, M.D.
Dr. Wildman received his Bachelor of Science with Honors from Duke University. He graduated from SUNY Stony Brook Medical School, where he earned the prestigious Award for Clinical Excellence. After an internship in Internal Medicine at Georgetown University Hospital, Dr. Wildman completed his dermatology residency at George Washington University Hospital, serving as Chief Resident during his final year. He was recruited to Weill Cornell Medical College in 2006 to expand the medical dermatology service and now serves as the Residency Director for the department.
Dr. Wildman has a comprehensive dermatology practice focusing on medical, surgical, and cosmetic dermatology. His patients range in age from one day old to one hundred years old. He has a particular expertise in psoriasis including treatments with phototherapy, biologics, and other systemic agents. He is also interested in the early detection of melanoma and non-melanoma skin cancers.
Clinical Profile (POPS)Pulmonology
Edward J. Schenck, M.D.
Abraham Sanders, M.D.
Lindsay Lief, M.D.
Lindsay Lief, M.D.
Lindsay Lief, MD is an Assistant Professor of Medicine in the Division of Pulmonary and Critical Care Medicine and the Associate Director of the Medical Intensive Care Unit at NewYork-Presbyterian/Weill Cornell Medical Center. Dr. Lief attended medical school at Temple University School of Medicine and completed her residency and fellowship at NewYork-Presbyterian (NYP) and Weill Cornell Medicine. After fellowship training, Dr. Lief was honored to serve as the Chief Medical Resident at NYP/Weill Cornell.
Dr. Lief devotes her clinical time to caring for critically ill patients and their families, both during their ICU stays and after discharge from the hospital. She has expertise in treating all types of critical illness including respiratory failure, septic shock and bleeding complications, particularly in patients with underlying myeloproliferative disorders and with a history of stem cell transplant. Her research interests are in identifying and treating unrecognized symptoms in critically ill patients; and in improving outcomes for both ICU patients and their families, as well as the staff providing their care.
Clinical Profile (POPS)
Robert Jeffrey Kaner, M.D.
Cardiology
Stephanie Feldman, M.D.
Stephanie Feldman, M.D.
Dr. Feldman is an Assistant Professor of Medicine in the Division of Cardiology of the Department of Medicine at Weill Cornell Medical College and an Attending Physician at New York Presbyterian-Weill Cornell Medical Center.
Dr. Feldman grew up in Framingham, Massachusetts and completed her undergraduate studies at the University of Pennsylvania. She earned her medical degree from Boston University School of Medicine, completed Internal Medicine residency at Beth Israel Deaconess Medical Center/Harvard Medical School, where she completed the Clinician Educator Track, fellowship in Cardiovascular Disease at Boston Medical Center/Boston University School of Medicine, and an additional fellowship in Cardio-Oncology at Memorial Sloan Kettering Cancer Center. After training, she founded and directed the Cardio-Oncology and Cardiac Amyloidosis programs at Rutgers New Jersey Medical School/University Hospital. In 2023, she joined the Cardiology Division at New York-Presbyterian/Weill Cornell Medical College as a full-time faculty member where she provides expertise in cardio-oncology, cardiac imaging, and medical education. She serves as the Director of the Cardio-Oncology program.
Dr. Feldman is board certified in Internal Medicine, Cardiovascular Diseases, Echocardiography, Nuclear Cardiology, and Cardio-Oncology. She is a fellow of the American College of Cardiology, and a member of the American Heart Association, American Society of Nuclear Cardiology, and the International Society of Cardio-Oncology.
Clinical Profile (POPS)
Jiwon Kim, M.D.
Jiwon Kim, M.D.
I am an Assistant Professor of Medicine (Cardiology) at Weill Cornell Medicine with an academic focus on translational cardiovascular imaging research. I trained at Beth Israel Deaconess Medical Center for Internal Medicine and Brown University for Cardiovascular Disease Fellowship. This training was followed by dedicated Advanced Cardiovascular Imaging Fellowship at Memorial Sloan Kettering Cancer Center. My research has focused on studying right heart physiology and remodeling using emerging echocardiography and MRI imaging techniques to improve risk stratification and treatment of patients with heart failure. I have a particular interest in cardiac sequelae of myeloproliferative neoplasms with attention to its impact on the right heart and right heart pressures.
Clinical Profile (POPS)Obstetrics
Vascular Surgery
Darren B. Schneider, M.D.
Darren B. Schneider, M.D.
Dr. Schneider is Chief of Vascular and Endovascular Surgery at Weill Cornell medical College, and Director of the Center for Vascular and Endovascular Surgery at New York-Presbyterian Hospital/Weill Cornell Medical Center. A graduate of Stanford University, he received his M.D. from the University of California, San Diego, School of Medicine, followed by General Surgery residency at the University of California, San Francisco (UCSF), a fellowship at the Gladstone Institute of Cardiovascular Surgery, and fellowships in interventional radiology and also vascular surgery at UCSF.
He is an internationally recognized expert in advanced minimally invasive vascular and endovascular procedures, and was one of the first surgeons in the country to apply advanced endovascular techniques for the treatment of carotid disease and peripheral arterial disease. His expertise also includes minimally invasive and open surgical techniques for treatment of varicose veins and deep vein thrombosis (DVT). He is perennially selected as one of the Best Doctors in America by Castle Connolly and US News World, as well as Best Doctors in New York.
Clinical Profile (POPS)Rheumatology
Susan M. Goodman, M.D.
Susan M. Goodman, M.D.
Dr. Goodman is Associate Professor of Medicine (Rheumatology) at Weill Cornell Medical College and Associate Attending Physician at the Hospital for Special Surgery (HSS). She specializes in the treatment of patients with inflammatory arthritis such as rheumatoid arthritis, psoriatic arthritis and spondyloarthritis. She also specializes in the perioperative care of patients with rheumatic diseases. She is Director of the Comprehensive Arthritis Clinical Research Program and Medical Chief of the Comprehensive Arthritis Program (CAP) at HSS.
Clinical Profile (POPS)
Jessica Gordon, M.D.
Jessica Gordon, M.D.
Jessica Gordon, MD, MSc is an Assistant Attending in the Department of Rheumatology at Hospital for Special Surgery (HSS) and Assistant Professor of Medicine at the Weill Cornell Medical College. She completed medical school at SUNY Stony Brook in 2002 and Internal Medicine Residency and Chief Residency at Georgetown University Hospital in Washington, DC in 2006. Dr. Gordon completed her fellowship in Rheumatology at HSS in 2010 and joined the Medical staff at HSS at that point in time. Dr. Gordon cares for patients who have myeloproliferative neoplasms and rheumatic disease.
Clinical Profile (POPS)Gastroenterology
Ellen J. Scherl, M.D.
Randy Longman, M.D., Ph.D.
Steven M. Lipkin, M.D., Ph.D.
Neurology
Matthew E. Fink, M.D.
Matthew E. Fink, M.D.
Dr. Fink is the Louis and Gertrude Feil Professor and Chair of the Department of Neurology at Weill Cornell Medical College, and Neurologist-in-Chief at New York Presbyterian Hospital/Weill Cornell Medical Center. In addition, he is Chief of the Division of Stroke and Critical Care Neurology. A graduate of the University of Pennsylvania, Dr. Fink received his M.D. from the University of Pittsburgh, followed by residency and Chief Residency at the Boston City Hospital. He completed his fellowship in Neurology at Columbia before joining its faculty and becoming the founding director of Columbia’s Neurology-Neurosurgery Intensive Care Unit.
Prior to joining the faculty of Cornell, Dr. Fink served as President and CEO of the Beth Israel Medical Center in New York. Editor of the monthly publication, "Neurology Alert," and past President of the New York State Neurological Society, Dr. Fink is a renowned expert in neurovascular diseases including stroke.
Clinical Profile (POPS)
Hooman Kamel, M.D.
Hooman Kamel, M.D.
Dr. Kamel is Assistant Professor of Neurology at Weill Cornell Medical College. A graduate of Harvard College, he received his M.D. from Columbia College of Physicians and Surgeons, and trained as a neurocritical care fellow at the University of California, San Francisco (UCSF). He is a widely respected expert in stroke and cerebrovascular disease. Dr. Kamel has been the recipient of many clinical and research awards, including the 2014 Pessin Stroke Leadership Prize of the American Academy of Neurology.
Clinical Profile (POPS)